BN Business News
Add your company to Business Communicator →

Business · 08/01/2021Updated: 10/17/2026 · 1 min read

FDA Reopens Comment Period for 503B Bulks List Notice

Summary

The FDA is reopening the comment period for a notice regarding the 503B Bulks List, which identifies bulk drug substances with clinical need, following a request from interested persons for additional time to submit comments.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →